Ramachandra Chowdappa1, Ajeet Ramamani Tiwari1, Namrata Ranganath2, Rekha V Kumar3. 1. Department of Surgical Oncology, Kidwai Cancer Institute, Bengaluru, India. 2. Department of Anaesthesia and Pain Relief, Kidwai Cancer Institute, Bengaluru, India. 3. Department of Pathology, Kidwai Cancer Institute, Bengaluru, India.
Abstract
BACKGROUND: Little has been reported regarding differences between malignancies that develop at the anastomotic site (ASC) and those that develop at the remnant stump (RSC) in gastric stump carcinomas (GSC). The purpose of our study was to compare clinical, pathological and survival characteristics of ASC patients with those of RSC patients. METHODS: Patients who underwent surgery for GSC between January 2005 and December 2017 were analyzed. Of the total 112 patients, 22 patients were excluded from the study due to extensive loss of data. Ninety patients underwent curative resection and were evaluated based on anatomic site at which they developed malignancy, i.e., ASC and RSC. Clinical, pathological and survival characteristics were assessed. RESULTS: As per Lauren's classification, diffuse and intestinal variety were significantly associated with ASC (P=0.0001) and RSC (P=0.0001) respectively. RSC was associated with lower pT [pT2, 15/33 (45.5%), P=0.0002]. ASC was significantly associated with higher pN [pN3, 30/57 (52.6%), P=0.0013], stage [stage III, 48/57 (84.2%), P=0.0022], positive mesenteric nodes (P=0.006) and poor 3-year survival (10.5% versus 36.4%, P=0.003). CONCLUSIONS: ASC is substantially different than RSC. ASC is more aggressive disease compared to RSC and has different pathophysiology, higher rates of nodal involvement (both primary and mesenteric), presents with higher stage and has significantly poor 3-year survival.
BACKGROUND: Little has been reported regarding differences between malignancies that develop at the anastomotic site (ASC) and those that develop at the remnant stump (RSC) in gastric stump carcinomas (GSC). The purpose of our study was to compare clinical, pathological and survival characteristics of ASC patients with those of RSC patients. METHODS: Patients who underwent surgery for GSC between January 2005 and December 2017 were analyzed. Of the total 112 patients, 22 patients were excluded from the study due to extensive loss of data. Ninety patients underwent curative resection and were evaluated based on anatomic site at which they developed malignancy, i.e., ASC and RSC. Clinical, pathological and survival characteristics were assessed. RESULTS: As per Lauren's classification, diffuse and intestinal variety were significantly associated with ASC (P=0.0001) and RSC (P=0.0001) respectively. RSC was associated with lower pT [pT2, 15/33 (45.5%), P=0.0002]. ASC was significantly associated with higher pN [pN3, 30/57 (52.6%), P=0.0013], stage [stage III, 48/57 (84.2%), P=0.0022], positive mesenteric nodes (P=0.006) and poor 3-year survival (10.5% versus 36.4%, P=0.003). CONCLUSIONS: ASC is substantially different than RSC. ASC is more aggressive disease compared to RSC and has different pathophysiology, higher rates of nodal involvement (both primary and mesenteric), presents with higher stage and has significantly poor 3-year survival.
Entities:
Keywords:
Gastric stump carcinoma (GSC); anastomotic site cancer; remnant stump cancer
Authors: Alberto Di Leo; Corrado Pedrazzani; Maria Bencivenga; Arianna Coniglio; Fausto Rosa; Paolo Morgani; Daniele Marrelli; Alberto Marchet; Luca Cozzaglio; Simone Giacopuzzi; Guido Alberto Massimo Tiberio; Giovanni Battista Doglietto; Giovanni Vittimberga; Franco Roviello; Francesco Ricci Journal: Ann Surg Oncol Date: 2014-03-18 Impact factor: 5.344
Authors: Paolo Morgagni; Andrea Gardini; Daniele Marrelli; Giovanni Vittimberga; Alberto Marchet; Giovanni de Manzoni; Maria Antonietta Di Cosmo; Gian Maria Rossi; Domenico Garcea; Franco Roviello Journal: Am J Surg Date: 2014-08-07 Impact factor: 2.565
Authors: Marcus Fernando Kodama Pertille Ramos; Marina Alessandra Pereira; Andre Roncon Dias; Anna Carolina Batista Dantas; Daniel Jose Szor; Ulysses Ribeiro; Bruno Zilberstein; Ivan Cecconello Journal: World J Gastrointest Surg Date: 2021-04-27